v3.25.3
License and Other Agreements - Additional Information (Detail) - USD ($)
$ in Millions
 1 Months Ended 9 Months Ended
Sep. 04, 2025
Nov. 01, 2023
Mar. 10, 2020
Oct. 22, 2019
Sep. 30, 2021
Sep. 30, 2025
Research And Development Arrangement Contract To Perform For Others [Line Items]            
Additional milestone payments $ 2.9          
Bausch Health Ireland Limited            
Research And Development Arrangement Contract To Perform For Others [Line Items]            
Upfront and milestone payments       $ 20.0    
Arctic Vision Limited | Minimum            
Research And Development Arrangement Contract To Perform For Others [Line Items]            
Threshold percentage of sales for tiered royalties     10.00%      
Arctic Vision Limited | Maximum            
Research And Development Arrangement Contract To Perform For Others [Line Items]            
Threshold percentage of sales for tiered royalties     12.00%      
XIPERE [Member] | Bausch Health Ireland Limited            
Research And Development Arrangement Contract To Perform For Others [Line Items]            
First cumulative net sales of products           $ 45.0
XIPERE [Member] | Bausch Health Ireland Limited | Maximum            
Research And Development Arrangement Contract To Perform For Others [Line Items]            
Additional milestone payments       $ 55.0    
License Arrangement | Arctic Vision Limited            
Research And Development Arrangement Contract To Perform For Others [Line Items]            
Consideration for territory expansion received         $ 3.0  
License Arrangement | Arctic Vision Limited | Upfront Payment            
Research And Development Arrangement Contract To Perform For Others [Line Items]            
Upfront and milestone payments     $ 10.5      
License Arrangement | Arctic Vision Limited | Maximum            
Research And Development Arrangement Contract To Perform For Others [Line Items]            
Development milestone payments     $ 22.0      
License Arrangement | BioCryst Pharmaceuticals, Inc            
Research And Development Arrangement Contract To Perform For Others [Line Items]            
Minimum sales to applied highest royalty rate   $ 1,500.0        
License Arrangement | BioCryst Pharmaceuticals, Inc | Upfront Payment            
Research And Development Arrangement Contract To Perform For Others [Line Items]            
License fee payment   5.0        
License Arrangement | BioCryst Pharmaceuticals, Inc | Maximum            
Research And Development Arrangement Contract To Perform For Others [Line Items]            
Milestone payments   30.0        
Clinical and regulatory milestone payments   47.5        
Global net product sales milestones   $ 2,000.0